Sartorius Accessia Pharma
ActiveSummary
The computed 12-month bankruptcy probability of Sartorius Accessia Pharma is 1.8% (moderate). The 2025 annual accounts show negative equity (-€2.0m) and a net result of €167,732. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 540 sector peers (NACE 77, financial year 2025). The company has been active since 2016 and the Belgian Official Gazette contains no insolvency or warning signals.
Articles of association
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Last Thursday of March at 19:00deed of 28-01-2025
- Other provisionsOther rules from the articles that fall under none of the themes above.
- 1 more provision in the deed, see the deed of 25-04-2024
Read from the deeds: 2 provisions, deed of 28-01-2025